The Kushner scion’s VC firm Thrive Capital nearly tripled its assets thanks to smart bets on OpenAI and SpaceX. Now he’s looking to spend some cash on the NBA’s Lakers.
AI’s big debt load. Moving backward on defense tech. Why we need to talk about CPUs. All that and more in this week’s Prototype.
The Chinese-owned social network has been flooded with advertisements pushing street drugs and prescription pills like codeine, benzos and Adderall.
Footage from Rockstar’s ‘GTA VI’ is being leaked by a hacker known as “CyberLeek,” sparking controversy and discourse—here’s what to know about the leaks.
TikTok made $9.1 billion and its first profit in Europe and Latin America but faces a wave of lawsuits and investigations from European regulators.
For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.
In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more.
Google says its buying Spirit Airlines’ data for $10 million.
Despite racking up more than $2 billion in losses while sticking to a do-it-yourself strategy, buy-now, pay-later pioneer Affirm is finally profitable—and worth $25 billion.
Chairman and CEO Wang Xingxing’s fortune surged nearly sevenfold to $16 billion as investors bet on China’s leading humanoid robot maker.